Anthony Vandersteen, MA, PhD, BM, FRCP

Anthony Vandersteen, MA, PhD, BM, FRCP

Geneticist (Canada)

Anthony Vandersteen, MA, PhD, BM, FRCP is a clinical geneticist with subspecialty training in heritable disorders of connective tissue. Dr. Vandersteen received his MA in Natural Sciences at Cambridge University and PhD in RNA chemistry from King’s College London University. He completed a two year postdoctoral fellowship in combinatorial chemistry and drug discovery at the Scripps Research Institute in La Jolla, USA, before returning to the UK to study medicine at the University of Southampton. He completed his internship and residency in internal medicine at various hospitals in the South of England, including general medicine and surgery, accident and emergency, respiratory, expedition and intensive care medicine, haematology, genetics and oncology. He gained membership of the royal college of physicians (London) in 2005 and began speciality training in Clinical Genetics in the London deanery (Guy’s and Great Ormond Street Hospitals), with an additional 6 month locum in Wellington, New Zealand. He worked as a consultant/ staff physician in Clinical Genetics for 4 years at the North West London Regional Genetics and UK National Ehlers-Danlos Syndrome (EDS) diagnostic service, with ongoing tutelage from Prof. F. Michael Pope and Dr. Glenda Sobey, visits to EDS specialist services in Ghent and Seattle. Joint clinics included those with Prof. Rodney Grahame (hypermobility syndrome), Prof. Francesco Muntoni (neuromuscular disorders) and Dr. Ben Jacobs (Royal National Orthopedic Hospital, skeletal and bone metabolism). A collaboration with Prof. Tim Aitman (Imperial College and Edinburgh University) was awarded an UK MRC grant to examine the role of next generation DNA sequencing in EDS patients. Dr. Vandersteen has international peer reviewed publications in various areas of chemistry, drug discovery, general medicine, genetics, dysmorphology and EDS. He has worked in numerous collaborations including deciphering developmental disorders (DDD), hereditary breast and ovarian cancer, FORGE (CHEO) and Filamin A related disorders (Prof. Stephen Robertson). Dr. Vandersteen and family recently emigrated to Canada, and he is a staff physician in the Maritime Medical Genetics Service at the IWK Health centre in Halifax, Nova Scotia, he is assistant professor at Dalhousie University. He currently sees patients in general genetics and connective tissue clinics, works in collaboration with pediatric physiotherapy, pain management and orthopedics, along with various emerging research and teaching collaborations across Canada. Dr. Vandersteen has a longterm interest in emerging therapies for rare Mendelian disorders.